I think it's the sheer lack of scientific information. None of the deals mean anything if they are largely tied to FDA approval and we have no confirmation that there is a positive result for the peptides/blood work.
If we go thru this call on Thursday without finding out where the science is, the SP is going to struggle, IMO.
(3)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links